[Federal Register Volume 63, Number 136 (Thursday, July 16, 1998)]
[Notices]
[Page 38417]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-18926]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Phase I Trial: Autologous, Tumor-pulsed Dendritic Cells.
    Date: August 3-4, 1998.
    Time: 8:00 AM to 6:00 PM.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver 
Spring, MD 20910.
    Contact Person: Martin H. Goldrosen, PhD, Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6130 Executive Boulevard, Room 635C, Rockville, MD 20852-
7408, (301) 496-7930.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: July 10, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-18926 Filed 7-15-98; 8:45 am]
BILLING CODE 4140-01-M